
BLTE
Healthcare · Biotechnology · $6.62B market cap
$164.35-5.61 (-3.3%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +4.8% over 90 days · 30-day revisions 3 up, 2 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Before the open | -0.73 | -0.65 | +11.0% |
| Aug 12, 2026 | Time not confirmed | -0.73 | -0.70 | +4.1% |
| May 20, 2026 | Before the open | -0.64 | -0.68 | -6.3% |
| Mar 2, 2026 | Before the open | -0.54 | -0.70 | -29.6% |
| Nov 10, 2025 | Before the open | -0.49 | -0.65 | -32.7% |
| Aug 11, 2025 | Before the open | -0.42 | -0.50 | -19.0% |
| May 14, 2025 | Before the open | -0.36 | -0.45 | -25.0% |
| Mar 17, 2025 | Time not confirmed | -0.32 | -0.32 | 0.0% |
| Nov 12, 2024 | Before the open | -0.30 | -0.28 | +6.7% |
| Aug 9, 2024 | After the close | -0.26 | -0.31 | -19.2% |
| May 14, 2024 | Before the open | -0.28 | -0.27 | +3.6% |
| Mar 11, 2024 | After the close | -0.30 | -0.25 | +16.7% |
| Nov 14, 2023 | Before the open | -0.32 |
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and…
| -0.40 |
| -25.0% |
| Aug 9, 2023 | Before the open | -0.30 | -0.26 | +13.3% |
| May 10, 2023 | After the close | -0.23 | -0.33 | -43.5% |
| Mar 31, 2023 | After the close | -0.17 | -0.37 | -117.6% |
| Nov 3, 2022 | After the close | -0.24 | -0.24 | 0.0% |
| Aug 10, 2022 | After the close | -0.28 | -0.07 | +75.0% |
| Apr 29, 2022 | After the close | -0.28 | -0.40 | -42.9% |
| Jan 21, 2022 | Time not confirmed | — | -0.20 | — |